Abstract Purpose of Review Anxiety and depressive disorders are highly prevalent,
frequently comorbid, and contribute to high rates of disability and death globally. They also …

Human epidemiological studies have identified links between nicotine intake and stress
disorders, including anxiety, depression and PTSD. Here we review the clinical evidence for …

Importance Improving treatment outcomes for smokers with major depressive disorder
(MDD) can have significant public health implications. Objective To evaluate the safety and …

Background To address the burden of tobacco use in underserved populations, our safety
net hospital developed a tobacco treatment intervention consisting of an “opt-out” electronic …

Background Smoking cessation interventions are being introduced into routine secondary
care in the United Kingdom (UK), but there are person and setting-related factors that could …

Background Knowledge brokering is a knowledge translation approach that has been
gaining popularity in Canada although the effectiveness is unknown. This study evaluated …

Introduction Though many interventions have been shown to be effective in helping smokers
quit, outcomes may differ between light and heavy smokers. We identified differences in …

Background The identification of variants in the nicotinic acetylcholine receptor (nAChR)
subunit genes associated with smoking phenotypes are increasingly important for …

A scientifically informed intervention to help smokers quit for life, based in cognitive-
behavioral therapy Cognitive-Behavioral Therapy, Mindfulness, and Hypnosis for Smoking …

Introduction Adults with depression have higher rates of cigarette smoking and are more
likely to relapse than those without depression. Pharmacological, psychological, and …